The effectiveness and value of lecanemab for early Alzheimer disease : A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Journal of managed care & specialty pharmacy - 29(2023), 9 vom: 12. Sept., Seite 1078-1083 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wright, Abigail C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 24.08.2023 Date Revised 23.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.18553/jmcp.2023.29.9.1078 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361085648 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361085648 | ||
| 003 | DE-627 | ||
| 005 | 20231226084410.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18553/jmcp.2023.29.9.1078 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM361085648 | ||
| 035 | |a (NLM)37610113 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wright, Abigail C |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The effectiveness and value of lecanemab for early Alzheimer disease |b A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.08.2023 | ||
| 500 | |a Date Revised 23.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a lecanemab |2 NLM | |
| 650 | 7 | |a 12PYH0FTU9 |2 NLM | |
| 700 | 1 | |a Lin, Grace A |e verfasserin |4 aut | |
| 700 | 1 | |a Whittington, Melanie D |e verfasserin |4 aut | |
| 700 | 1 | |a Agboola, Foluso |e verfasserin |4 aut | |
| 700 | 1 | |a Herron-Smith, Serina |e verfasserin |4 aut | |
| 700 | 1 | |a Rind, David |e verfasserin |4 aut | |
| 700 | 1 | |a Pearson, Steven D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of managed care & specialty pharmacy |d 2014 |g 29(2023), 9 vom: 12. Sept., Seite 1078-1083 |w (DE-627)NLM235806323 |x 2376-1032 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:9 |g day:12 |g month:09 |g pages:1078-1083 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18553/jmcp.2023.29.9.1078 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 9 |b 12 |c 09 |h 1078-1083 | ||